These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25840793)

  • 21. Energy expenditure at rest and during sleep in children with Prader-Willi syndrome is explained by body composition.
    van Mil EA; Westerterp KR; Gerver WJ; Curfs LM; Schrander-Stumpel CT; Kester AD; Saris WH
    Am J Clin Nutr; 2000 Mar; 71(3):752-6. PubMed ID: 10702169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic syndrome in adult patients with Prader-Willi syndrome.
    Grugni G; Crinò A; Bedogni G; Cappa M; Sartorio A; Corrias A; Di Candia S; Gargantini L; Iughetti L; Pagano C; Ragusa L; Salvatoni A; Spera S; Vettor R; Chiumello G; Brambilla P
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1134-40. PubMed ID: 23220075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between metabolic syndrome, cytokines and physical activity in obese youth with and without Prader-Willi syndrome.
    McAlister KL; Fisher KL; Dumont-Driscoll MC; Rubin DA
    J Pediatr Endocrinol Metab; 2018 Aug; 31(8):837-845. PubMed ID: 29975666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
    Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity.
    Höybye C; Hilding A; Jacobsson H; Thorén M
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3590-7. PubMed ID: 12161480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolomic profiling of Prader-Willi syndrome compared with essential obesity.
    Rigamonti AE; Polledri E; Favero C; Caroli D; Bondesan A; Grugni G; Mai S; Cella SG; Fustinoni S; Sartorio A
    Front Endocrinol (Lausanne); 2024; 15():1386265. PubMed ID: 38812813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prader-Willi syndrome: relationship of adiposity to plasma leptin levels.
    Pietrobelli A; Allison DB; Faith MS; Beccaria L; Bosio L; Chiumello G; Campfield LA; Heymsfield SB
    Obes Res; 1998 May; 6(3):196-201. PubMed ID: 9618123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects.
    Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Schroor EJ; Van Alfen AA; Van Leeuwen M; Van Pinxteren-Nagler E; Van Wieringen H; Vreuls RC; Zwaveling-Soonawala N; de Ridder MA; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4013-22. PubMed ID: 24001750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postprandial adiponectin levels are unlikely to contribute to the pathogenesis of obesity in Prader-Willi syndrome.
    Caixàs A; Giménez-Palop O; Giménez-Pérez G; Potau N; Berlanga E; González-Glemente JM; Arroyo J; Laferrère B; Mauricio D
    Horm Res; 2006; 65(1):39-45. PubMed ID: 16374018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial.
    Mogul HR; Lee PD; Whitman BY; Zipf WB; Frey M; Myers S; Cahan M; Pinyerd B; Southren AL
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1238-45. PubMed ID: 18211968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Body composition in Prader-Willi syndrome compared with nonsyndromal obesity: Relationship to physical activity and growth hormone function.
    van Mil EG; Westerterp KR; Gerver WJ; Van Marken Lichtenbelt WD; Kester AD; Saris WH
    J Pediatr; 2001 Nov; 139(5):708-14. PubMed ID: 11713451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome.
    Sze L; Purtell L; Jenkins A; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1314-9. PubMed ID: 21632815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Sun's Vitamin in Adult Patients Affected by Prader-Willi Syndrome.
    Barrea L; Muscogiuri G; Pugliese G; Aprano S; de Alteriis G; Di Somma C; Colao A; Savastano S
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32316673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome.
    Gondoni LA; Vismara L; Marzullo P; Vettor R; Liuzzi A; Grugni G
    J Endocrinol Invest; 2008 Sep; 31(9):765-72. PubMed ID: 18997487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gait strategy and body composition in patients with Prader-Willi syndrome.
    Cimolin V; Cau N; Galli M; Pau M; Parisio C; Saezza A; Grugni G; Capodaglio P
    Eat Weight Disord; 2021 Feb; 26(1):115-124. PubMed ID: 31797332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there growth hormone deficiency in prader-willi Syndrome? Six arguments to support the presence of hypothalamic growth hormone deficiency in Prader-Willi syndrome.
    Eiholzer U; Bachmann S; l'Allemand D
    Horm Res; 2000; 53 Suppl 3():44-52. PubMed ID: 10971104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle-bone characteristics in children with Prader-Willi syndrome.
    Edouard T; Deal C; Van Vliet G; Gaulin N; Moreau A; Rauch F; Alos N
    J Clin Endocrinol Metab; 2012 Feb; 97(2):E275-81. PubMed ID: 22162467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A reduced-energy intake, well-balanced diet improves weight control in children with Prader-Willi syndrome.
    Miller JL; Lynn CH; Shuster J; Driscoll DJ
    J Hum Nutr Diet; 2013 Feb; 26(1):2-9. PubMed ID: 23078343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy.
    Festen DA; van Toorenenbergen A; Duivenvoorden HJ; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1549-54. PubMed ID: 17264186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE; Carrel AL; Whitman BY; Allen DB
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.